Daiichi had acquired the Zenotech stake following its acquisition of Ranbaxy. At the time of the acquisition, Ranbaxy had about 47% stake in Zenotech. However, Zenotech's promoter Jayaram Chigurupati continues to hold about 25% stake in his company, while others hold around 8%.
FULL ARTICLE AT Daily News & Analysis